Publication Cover
Progress in Palliative Care
Science and the Art of Caring
Volume 30, 2022 - Issue 6
139
Views
0
CrossRef citations to date
0
Altmetric
Articles

The writing was on the wall: Decision making near the end of life in advanced liver disease

&

References

  • Williams R, Aspinall R, Bellis M, Camps-Walsh G, Cramp M, Dhawan A, et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014;384:1953–97. DOI: 10.1016/S0140-6736(14)61838-9.
  • National End of Life Intelligence Network. Deaths from liver disease: implications for end of life care in England. 2012.
  • Williams R, Alexander G, Aspinall R, Bosanquet J, Camps-Walsh G, Cramp M, et al. New metrics for the Lancet standing commission on liver disease in the UK. Lancet 2017;389:2053–80. DOI: 10.1016/S0140-6736(16)32234-6.
  • Kathpalia P, Smith A, Lai JC. Underutilization of palliative care services in the liver transplant population. World J Transplant 2016;6:594–8. DOI: 10.5500/wjt.v6.i3.594.
  • Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol 2014;12:692–8. DOI: 10.1016/j.cgh.2013.08.027.
  • Mazzarelli C, Prentice WM, Heneghan MA, Belli LS, Agarwal K, Cannon MD. Palliative care in end-stage liver disease: time to do better? Liver Transplant 2018;24:961–8. DOI: 10.1002/lt.25193.
  • Carbonneau M, Davyduke T, Spiers J, Brisebois A, Ismond K, Tandon P. Patient views on advance care planning in cirrhosis: A qualitative analysis. Can J Gastroenterol Hepatol 2018;2018:4040518. DOI: 10.1155/2018/4040518.
  • Hudson BE, Ameneshoa K, Gopfert A, Goddard R, Forbes K, Verne J, et al. Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention. Frontline Gastroenterol 2017;8:45–52. DOI: 10.1136/flgastro-2016-100734.
  • Baumann AJ, Wheeler DS, James M, Turner R, Siegel A, Navarro VJ. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manag 2015;50:882–6. e882. DOI: 10.1016/j.jpainsymman.2015.07.014.
  • Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther 2017;46:16–25. DOI: 10.1111/apt.14078.
  • Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, et al. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transplant 2008;14:1100–6. DOI: 10.1002/lt.21398.
  • NHS Blood and transplant - Annual report on liver transplantation: report for 2017/2018. 2018.
  • El-Jawahri A, Greer JA, Pirl WF, Park ER, Jackson VA, Back AL, et al. Effects of early integrated palliative care on caregivers of patients with lung and gastrointestinal cancer: a randomized clinical trial. Oncologist 2017;22:1528–34. DOI: 10.1634/theoncologist.2017-0227.
  • Rush B, Walley KR, Celi LA, Rajoriya N, Brahmania M. Palliative care access for hospitalized patients with end-stage liver disease across the United States. Hepatology 2017;66:1585–91. DOI: 10.1002/hep.29297.
  • Ufere NN, Donlan J, Waldman L, Dienstag JL, Friedman LS, Corey KE, et al. Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease. Clin Gastroenterol Hepatol 2019;17:2592–9. DOI: 10.1016/j.cgh.2019.03.022.
  • Kendall M, Carduff E, Lloyd A, Kimbell B, Cavers D, Buckingham S, et al. Different experiences and goals in different advanced diseases: comparing serial interviews with patients with cancer, organ failure, or frailty and their family and professional carers. J Pain Symptom Manag 2015;50:216–24. DOI: 10.1016/j.jpainsymman.2015.02.017.
  • Kubiliun MJ, Rich NE, Singal A, Mufti AR. Pro: liver transplantation should be considered in select patients with acute alcoholic hepatitis. Clin Liver Dis (Hoboken) 2019;13:140–3. DOI: 10.1002/cld.780.
  • Berry PA, Peck M, Standley T, Thomson SJ. Do critically ill liver patients experience negative bias? A web-based survey examining doctors opinions to critical care escalation. Frontline Gastroenterol 2016;7:10–15. DOI: 10.1136/flgastro-2015-100608.
  • Glannon W. Responsibility, alcoholism, and liver transplantation. J Med Philos 1998;23:31–49. DOI: 10.1076/jmep.23.1.31.2595.
  • Ball D. Addiction science and its genetics. Addiction 2008;103:360–7. DOI: 10.1111/j.1360-0443.2007.02061.x.
  • Cholongitas E, Betrosian A, Senzolo M, Shaw S, Patch D, Manousou P, et al. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol 2008;23:1223–7. DOI: 10.1111/j.1440-1746.2007.05269.x.
  • Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology 2015;62:243–52. DOI: 10.1002/hep.27849.
  • MacDonald AJ, Olson J, Karvellas CJ. Critical care considerations in the management of acute-on-chronic liver failure. Curr Opin Crit Care 2020;26:171–9. DOI: 10.1097/MCC.0000000000000698.
  • Berry PA, Thomson SJ, Rahman TM, Ala A. Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis. Aliment Pharmacol Ther 2013;37:174–82. DOI: 10.1111/apt.12133.
  • Artru F, Louvet A, Ruiz I, Levesque E, Labreuche J, Ursic-Bedoya J, et al. Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3. J Hepatol 2017;67:708–15. DOI: 10.1016/j.jhep.2017.06.009.
  • Sundaram V, Mahmud N, Perricone G, Katarey D, Wong RJ, Karvellas CJ, et al. Longterm outcomes of patients undergoing liver transplantation for acute-on-chronic liver failure. Liver Transplant 2020;26:1594–602. DOI: 10.1002/lt.25831.
  • Trebicka J, Sundaram V, Moreau R, Jalan R. Liver transplantation for acute-on-chronic liver failure: science or fiction? Liver Transplant 2020;26:906–15. DOI: 10.1002/lt.25788.
  • Im GY, Cameron AM, Lucey MR. Liver transplantation for alcoholic hepatitis. J Hepatol 2019;70:328–34. DOI: 10.1016/j.jhep.2018.11.007.
  • Singal AK, Bashar H, Anand BS, Jampana SC, Singal V, Kuo Y-F. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database. Hepatology 2012;55:1398–405. DOI: 10.1002/hep.25544.
  • Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628–37. DOI: 10.1002/lt.500030613.
  • Neuberger J, Schulz KH, Day C, Fleig W, Berlakovich GA, Berenguer M, et al. Transplantation for alcoholic liver disease. J Hepatol 2002;36:130–7. DOI: 10.1016/s0168-8278(01)00278-1.
  • DiMartini A, Day N, Dew MA, Javed L, Fitzgerald MG, Jain A, et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transplant 2006;12:813–20. DOI: 10.1002/lt.20688.
  • Santivasi WL, Strand JJ, Mueller PS, Beckman TJ. The organ transplant imperative. Mayo Clin Proc 2017;92:940–6. DOI: 10.1016/j.mayocp.2017.03.005.
  • Tirkkonen J, Olkkola KT, Tenhunen J, Hoppu S. Ethically justified treatment limitations in emergency situations. Eur j Emerg Med 2016;23:214–18. DOI: 10.1097/MEJ.0000000000000240.
  • Pearse W, Oprescu F, Endacott J, Goodman S, Hyde M, O’Neill M. Advance care planning in the context of clinical deterioration: a systematic review of the literature. Palliative Care 2019;12. DOI: 10.1177/1178224218823509.
  • Sprung CL, Cohen SL, Sjokvist P, Baras M, Bulow H-H, Hovilehto S, et al. End-of-life practices in European intensive care units: the ethicus study. JAMA 2003;290:790–7. DOI: 10.1001/jama.290.6.790.
  • Esteban A, Gordo F, Solsona JF, Alía I, Caballero J, Bouza C, et al. Withdrawing and withholding life support in the intensive care unit: a Spanish prospective multi-centre observational study. Intensive Care Med 2001;27:1744–9. DOI: 10.1007/s00134-001-1111-7.
  • White DB, Curtis JR, Lo B, Luce JM. Decisions to limit life-sustaining treatment for critically ill patients who lack both decision-making capacity and surrogate decision-makers. Crit Care Med 2006;34:2053–9. DOI: 10.1097/01.CCM.0000227654.38708.C1.
  • Gedge E, Giacomini M, Cook D. Withholding and withdrawing life support in critical care settings: ethical issues concerning consent. J Med Ethics 2007;33:215–18. DOI: 10.1136/jme.2006.017038.
  • Bowling A, Ebrahim S. Measuring patients’ preferences for treatment and perceptions of risk. Qual Health Care 2001;10(Suppl 1):i2–8. DOI: 10.1136/qhc.0100002.
  • Berry P, Cheent K, Lewis H, Peck M. Navigating the benefits and burdens of life-saving treatment in severely decompensated cirrhosis: an illustrative, multisourced narrative. BMJ Case Rep 2017;2017. DOI: 10.1136/bcr-2017-219320.
  • Hjorth M, Svanberg A, Sjoberg D, Rorsman F, Kaminsky E. Liver cirrhosis turns life into an unpredictable roller coaster: a qualitative interview study. J Clin Nurs 2020;29:4532–43. DOI: 10.1111/jocn.15478.
  • Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ 2005;330:1007–11. DOI: 10.1136/bmj.330.7498.1007.
  • Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, et al. The 3-month readmission rate remains unacceptably high in a large north American cohort of patients with cirrhosis. Hepatology 2016;64:200–8. DOI: 10.1002/hep.28414.
  • Kimbell B, Boyd K, Kendall M, Iredale J, Murray SA. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open 2015;5:e009241. DOI: 10.1136/bmjopen-2015-009241.
  • Kimbell B, Murray SA, Byrne H, Baird A, Hayes PC, MacGilchrist A, et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med 2018;32:919–29. DOI: 10.1177/0269216318760441.
  • Low J, Davis S, Vickerstaff V, Greenslade L, Hopkins K, Langford A, et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open 2017;7:e016887. DOI: 10.1136/bmjopen-2017-016887.
  • Koffman J, Yorganci E, Murtagh F, Yi D, Gao W, Barclay S, et al. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the improve care feasibility cluster RCT. Health Technol Assess 2019;23:1–150. DOI: 10.3310/hta23550.
  • Shinall MC, Jr., Karlekar M, Martin S, Gatto CL, Misra S, Chung CY, et al. COMPASS: a pilot trial of an early palliative care intervention for patients with end-stage liver disease. J Pain Symptom Manag 2019;58:614–22. e613. DOI: 10.1016/j.jpainsymman.2019.06.023.
  • Parry R, Land V, Seymour J. How to communicate with patients about future illness progression and end of life: a systematic review. BMJ Support Palliat Care 2014;4:331–41. DOI: 10.1136/bmjspcare-2014-000649.
  • Boyd K, Kimbell B, Murray S, Iredale J. A “good death” with irreversible liver disease: talking with patients and families about deteriorating health and dying. Clin Liver Dis (Hoboken) 2015;6:15–18. DOI: 10.1002/cld.479.
  • Hawkes CA, Fritz Z, Deas G, Ahmedzai SH, Richardson A, Pitcher D, et al. Development of the recommended summary plan for emergency care and treatment (ReSPECT). Resuscitation 2020;148:98–107. DOI: 10.1016/j.resuscitation.2020.01.003.
  • Logan RL, Scott PJ. Uncertainty in clinical practice: implications for quality and costs of health care. Lancet 1996;347:595–8. DOI: 10.1016/s0140-6736(96)91284-2.
  • McPhail MJ, Auzinger G, Bernal W, Wendon JA. Decisions on futility in patients with cirrhosis and organ failure. Hepatology 2016;64:986. DOI: 10.1002/hep.28539.
  • Simpkin AL, Schwartzstein RM. Tolerating uncertainty - the next medical revolution? N Engl J Med 2016;375:1713–15. DOI: 10.1056/NEJMp1606402.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.